---
$id: https://graph.org.ai/products/commodity/51302311
$type: Product
source: UNSPSC
code: "51302311"
title: "Doconazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doconazole

**UNSPSC Code**: 51302311
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C26H22Cl2N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VR021VC9TY, chemically known as 1h-imidazole, 1-((4-(((1,1-biphenyl)-4-yloxy)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-, cis- but generally known as doconazole, which bears US NIH Compound Identifier 65488. European Medicines Agency schedules Doconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06346MIG. The term DOCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). DOCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doconazole under HS 29349990 and SITC 51579. As of Q4 2014, DOCONAZOLE remains the US FDA Preferred Term for this commodity. Doconazole bears US NLM identifiers UMLS ID C1880384 and NCI Concept Code C65454. SMILES: CLC1C(C2(OC(CO2)COC2CCC(CC2)C2CCCCC2)CN2CCNC2)CCC(CL)C1.

